Pipeline run for this draft
Generated note
The study body reports 24.5 months from diagnosis; for maintenance patients, it reports 17.2 months from first immunization. Counting from diagnosis can make survival after starting VAXIRA appear longer. https://mediccreview.org/racotumomab-non-small-cell-lung-cancer-maintenance-treatment/
Source post
🇨🇺 Cuba has done it again. Meet VAXIRA® — a therapeutic cancer vaccine developed by Cuban and Argentine scientists that helps the immune system recognise and destroy lung cancer cells. Approved in both Cuba and Argentina for advanced non-small cell lung cancer. 🔬 It works by mimicking a molecule found on cancer cells but almost entirely absent in healthy human tissue — meaning it targets tumours with remarkable precision and very few side effects. 📊 Clinical trials showed a significant improvement in survival for advanced lung cancer patients, with 1-year survival nearly doubling compared to the control group. Real-world data shows median survival of up to 24.5 months in maintenance therapy. 💉 Minimal side effects. Suitable for long-term use. Affordable and accessible — unlike many Western immunotherapies that price patients out of treatment. And in 2025, VAXIRA® received Cuba's National Technological Innovation Award. All of this achieved by a country under decades of US economic blockade. The United States spends billions on cancer research. Cuba, under sanctions, develops vaccines the world hasn't seen before. 🇨🇺🔬 #VAXIRA #CubanScience #LungCancer #CancerResearch #Biotechnology
Pipeline steps
17 steps- ✓
- ✓
- ✓
- ✓
- ✓
- ✓
- ✓
- ✓
- ✓
- ✓
- ✓
- ✓
- ✓
- ✓
- ✓
- ✓
- ✕
generate_note.pre_filter
- Started
- May 30, 2026, 20:43:23
- Finished
- May 30, 2026, 20:43:27
- Duration
- 4.21 s
Input snapshot
{
"post_text": "[Target Post]\n🇨🇺 Cuba has done it again.\n\nMeet VAXIRA® — a therapeutic cancer vaccine developed by Cuban and Argentine scientists that helps the immune system recognise and destroy lung cancer cells. Approved in both Cuba and Argentina for advanced non-small cell lung cancer.\n\n🔬 It works by mimicking a molecule found on cancer cells but almost entirely absent in healthy human tissue — meaning it targets tumours with remarkable precision and very few side effects.\n\n📊 Clinical trials showed a sign"
}Output snapshot
{
"has_factual_claims": true
}